Medicofarma Biotech SA (WSE:MDB)

Market Cap	18.35M
Revenue (ttm)	464.51K
Net Income (ttm)	-3.00M
Shares Out	67.98M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,204
Average Volume	19,990
Open	0.2680
Previous Close	0.2690
Day's Range	0.2550 - 0.2850
52-Week Range	0.2310 - 0.7880
Beta	3.46
RSI	46.36
Earnings Date	Aug 7, 2025

About Medicofarma Biotech

Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products. The company is involved in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. It also offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics; and covid-19 test kits, such as real time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna. Medicofarma Biotech SA...

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2001
• Employees: 20
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MDB

Financial Performance

In 2024, Medicofarma Biotech's revenue was 1.22 million, an increase of 63.14% compared to the previous year's 750,809. Losses were -2.30 million, -33.11% less than in 2023.